Chronic phenmetrazine treatment promotes D2 dopaminergic and α2-adrenergic receptor desensitization and alters phosphorylation of signaling proteins and local cerebral glucose metabolism in the rat brain

doi:10.1016/j.brainres.2021.147387

Paper

Chronic phenmetrazine treatment promotes D2 dopaminergic and α2-adrenergic receptor desensitization and alters phosphorylation of signaling proteins and local cerebral glucose metabolism in the rat brain

Published Feb 22, 2021 · Bradley M Keegan, Annie L. Dreitzler, A. Howlett

Brain Research

Q2 SJR score

2

Citations

0

Influential Citations

Full text

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Chronic phenmetrazine treatment promotes D2 dopaminergic and 2-adrenergic receptor desensitization and alters phosphorylation of signaling proteins in the rat brain.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Chronic phenmetrazine treatment promotes D2 dopaminergic and α2-adrenergic receptor desensitization and alters phosphorylation of signaling proteins and local cerebral glucose metabolism in the rat brain

References

Citations